Literature DB >> 25881969

Targeting the sarcomere to correct muscle function.

Peter M Hwang1, Brian D Sykes2.   

Abstract

Various human diseases can disrupt the balance between muscle contraction and relaxation. Sarcomeric modulators can be used to readjust this balance either indirectly by intervening in signalling pathways or directly through interaction with the muscle proteins that control contraction. Such agents represent a novel approach to treating any condition in which striated muscle function is compromised, including heart failure, cardiomyopathies, skeletal myopathies and a wide range of neuromuscular conditions. Here, we review agents that modulate the mechanical function of the sarcomere, focusing on emerging compounds that target myosin or the troponin complex.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25881969     DOI: 10.1038/nrd4554

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  198 in total

1.  Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form.

Authors:  Soichi Takeda; Atsuko Yamashita; Kayo Maeda; Yuichiro Maéda
Journal:  Nature       Date:  2003-07-03       Impact factor: 49.962

2.  Mutations in TNNT3 cause multiple congenital contractures: a second locus for distal arthrogryposis type 2B.

Authors:  Sandy S Sung; Anna-Marie E Brassington; Patrycja A Krakowiak; John C Carey; Lynn B Jorde; Michael Bamshad
Journal:  Am J Hum Genet       Date:  2003-07       Impact factor: 11.025

Review 3.  Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities.

Authors:  Saskia Schlossarek; Giulia Mearini; Lucie Carrier
Journal:  J Mol Cell Cardiol       Date:  2011-02-01       Impact factor: 5.000

4.  Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension.

Authors:  Martina Krüger; Wolfgang A Linke
Journal:  J Muscle Res Cell Motil       Date:  2006-08-04       Impact factor: 2.698

5.  The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin.

Authors:  J A Spudich; S Watt
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

6.  Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.

Authors:  John R Teerlink; G Michael Felker; John J V McMurray; Piotr Ponikowski; Marco Metra; Gerasimos S Filippatos; Justin A Ezekowitz; Kenneth Dickstein; John G F Cleland; Jae B Kim; Lei Lei; Beat Knusel; Andrew A Wolff; Fady I Malik; Scott M Wasserman
Journal:  J Am Coll Cardiol       Date:  2016-03-29       Impact factor: 24.094

Review 7.  Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era.

Authors:  Polakit Teekakirikul; Melissa A Kelly; Heidi L Rehm; Neal K Lakdawala; Birgit H Funke
Journal:  J Mol Diagn       Date:  2012-12-27       Impact factor: 5.568

Review 8.  Compartmentation of cAMP signalling in cardiomyocytes in health and disease.

Authors:  R K Perera; V O Nikolaev
Journal:  Acta Physiol (Oxf)       Date:  2013-02-26       Impact factor: 6.311

9.  Structural basis for the in situ Ca(2+) sensitization of cardiac troponin C by positive feedback from force-generating myosin cross-bridges.

Authors:  Daniel C Rieck; King-Lun Li; Yexin Ouyang; R John Solaro; Wen-Ji Dong
Journal:  Arch Biochem Biophys       Date:  2013-07-26       Impact factor: 4.013

10.  Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

Authors:  Milton Packer; Wilson Colucci; Lloyd Fisher; Barry M Massie; John R Teerlink; James Young; Robert J Padley; Roopal Thakkar; Leticia Delgado-Herrera; Jeffrey Salon; Chris Garratt; Bidan Huang; Toni Sarapohja
Journal:  JACC Heart Fail       Date:  2013-04-01       Impact factor: 12.035

View more
  47 in total

Review 1.  Designing proteins to combat disease: Cardiac troponin C as an example.

Authors:  Jonathan P Davis; Vikram Shettigar; Svetlana B Tikunova; Sean C Little; Bin Liu; Jalal K Siddiqui; Paul M L Janssen; Mark T Ziolo; Shane D Walton
Journal:  Arch Biochem Biophys       Date:  2016-02-18       Impact factor: 4.013

Review 2.  Therapeutic Strategies Targeting Inherited Cardiomyopathies.

Authors:  Kenneth Varian; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 3.  High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.

Authors:  Juan C Del Álamo; Derek Lemons; Ricardo Serrano; Alex Savchenko; Fabio Cerignoli; Rolf Bodmer; Mark Mercola
Journal:  Biochim Biophys Acta       Date:  2016-03-04

4.  Actin-binding compounds, previously discovered by FRET-based high-throughput screening, differentially affect skeletal and cardiac muscle.

Authors:  Piyali Guhathakurta; Lien A Phung; Ewa Prochniewicz; Sarah Lichtenberger; Anna Wilson; David D Thomas
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

5.  Actomyosin-Mediated Tension Orchestrates Uncoupled Respiration in Adipose Tissues.

Authors:  Kevin M Tharp; Michael S Kang; Greg A Timblin; Jon Dempersmier; Garret E Dempsey; Peter-James H Zushin; Jaime Benavides; Catherine Choi; Catherine X Li; Amit K Jha; Shingo Kajimura; Kevin E Healy; Hei Sook Sul; Kaoru Saijo; Sanjay Kumar; Andreas Stahl
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

Review 6.  Biophysical Derangements in Genetic Cardiomyopathies.

Authors:  Melissa L Lynn; Sarah J Lehman; Jil C Tardiff
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

Review 7.  Strategies for targeting the cardiac sarcomere: avenues for novel drug discovery.

Authors:  Joshua B Holmes; Chang Yoon Doh; Ranganath Mamidi; Jiayang Li; Julian E Stelzer
Journal:  Expert Opin Drug Discov       Date:  2020-02-18       Impact factor: 6.098

8.  Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilaments.

Authors:  Brian R Thompson; Joshua Martindale; Joseph M Metzger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-13       Impact factor: 4.733

9.  Zebrafish Embryonic Slow Muscle Is a Rapid System for Genetic Analysis of Sarcomere Organization by CRISPR/Cas9, but Not NgAgo.

Authors:  Mengxin Cai; Yufeng Si; Jianshe Zhang; Zhenjun Tian; Shaojun Du
Journal:  Mar Biotechnol (NY)       Date:  2018-01-27       Impact factor: 3.619

10.  Top-Down Targeted Proteomics Reveals Decrease in Myosin Regulatory Light-Chain Phosphorylation That Contributes to Sarcopenic Muscle Dysfunction.

Authors:  Zachery R Gregorich; Ying Peng; Wenxuan Cai; Yutong Jin; Liming Wei; Albert J Chen; Susan H McKiernan; Judd M Aiken; Richard L Moss; Gary M Diffee; Ying Ge
Journal:  J Proteome Res       Date:  2016-07-13       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.